ArticleOncology letters2024
Single‑agent nintedanib suppresses metastatic osteosarcoma growth by inhibiting tumor vascular formation.
Takatsune Shimizu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it